VIKING GLOBAL INVESTORS LP - Q3 2019 holdings

$19.2 Billion is the total value of VIKING GLOBAL INVESTORS LP's 62 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 88.9% .

 Value Shares↓ Weighting
AMZN BuyAMAZON COM INC$1,570,537,000
+3.3%
904,734
+12.7%
8.18%
+19.9%
NFLX BuyNETFLIX INC$1,160,017,000
+52.7%
4,334,569
+109.6%
6.04%
+77.3%
CRM BuySALESFORCE COM INC$732,108,000
+65.1%
4,932,010
+68.8%
3.81%
+91.7%
SQ BuySQUARE INCcl a$621,380,000
+222.4%
10,030,341
+277.5%
3.24%
+274.2%
MNST BuyMONSTER BEVERAGE CORP NEW$611,623,000
+8.2%
10,534,323
+19.0%
3.19%
+25.7%
ILMN BuyILLUMINA INC$586,219,000
+16.1%
1,926,956
+40.5%
3.05%
+34.8%
LOW BuyLOWES COS INC$536,029,000
+284.6%
4,874,766
+253.0%
2.79%
+346.7%
NOW NewSERVICENOW INC$449,491,0001,770,697
+100.0%
2.34%
UBER BuyUBER TECHNOLOGIES INC$441,829,000
-28.7%
14,500,445
+8.5%
2.30%
-17.3%
BSX BuyBOSTON SCIENTIFIC CORP$423,829,000
+7.2%
10,416,047
+13.3%
2.21%
+24.5%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$368,787,000
+270.6%
2,205,268
+275.5%
1.92%
+329.8%
FTV NewFORTIVE CORP$331,863,0004,840,472
+100.0%
1.73%
EQH BuyAXA EQUITABLE HLDGS INC$236,645,000
+28.1%
10,678,948
+20.8%
1.23%
+48.7%
GDI BuyGARDNER DENVER HLDGS INC$224,412,000
+405.7%
7,932,557
+518.5%
1.17%
+487.4%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$206,116,000
-7.1%
3,058,104
+18.1%
1.07%
+7.8%
GH NewGUARDANT HEALTH INC$183,475,0002,874,428
+100.0%
0.96%
AIZ BuyASSURANT INC$177,897,000
+364.0%
1,413,897
+292.3%
0.93%
+439.0%
COUP BuyCOUPA SOFTWARE INC$172,811,000
+36.8%
1,333,724
+33.7%
0.90%
+58.7%
MOH NewMOLINA HEALTHCARE INC$161,295,0001,470,061
+100.0%
0.84%
MIDD NewMIDDLEBY CORP$130,446,0001,115,875
+100.0%
0.68%
ATH BuyATHENE HLDG LTDcl a$108,879,000
+62.7%
2,588,658
+66.5%
0.57%
+89.0%
GRUB BuyGRUBHUB INC$98,557,000
-0.4%
1,753,374
+38.1%
0.51%
+15.5%
BPMC BuyBLUEPRINT MEDICINES CORP$58,896,000
+13.3%
801,639
+45.5%
0.31%
+31.8%
PGR NewPROGRESSIVE CORP OHIO$53,637,000694,330
+100.0%
0.28%
URI NewUNITED RENTALS INC$50,951,000408,782
+100.0%
0.26%
EW NewEDWARDS LIFESCIENCES CORP$44,894,000204,148
+100.0%
0.23%
SAGE NewSAGE THERAPEUTICS INC$36,962,000263,466
+100.0%
0.19%
NVST NewENVISTA HLDGS CORP$32,014,0001,148,263
+100.0%
0.17%
DDOG NewDATADOG INC$30,519,000899,999
+100.0%
0.16%
NET NewCLOUDFLARE INC$27,026,0001,455,336
+100.0%
0.14%
GMAB NewGENMAB A Ssponsored ads$12,013,000592,966
+100.0%
0.06%
CVNA NewCARVANA COcl a$7,939,000120,287
+100.0%
0.04%
TXG New10X GENOMICS INC$3,582,00071,069
+100.0%
0.02%
LIFE NewATYR PHARMA INC$802,000229,283
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VISA INC36Q3 20237.0%
AMAZON COM INC34Q3 202310.6%
META PLATFORMS INC34Q3 202310.4%
MICROSOFT CORP30Q3 20239.1%
THERMO FISHER SCIENTIFIC INC29Q3 20235.4%
NETFLIX INC26Q2 20236.0%
MASTERCARD INCORPORATED25Q3 20233.9%
ELEVANCE HEALTH INC24Q2 202310.2%
ALPHABET INC22Q2 20219.3%
UNITEDHEALTH GROUP INC22Q3 20235.3%

View VIKING GLOBAL INVESTORS LP's complete holdings history.

Latest significant ownerships (13-D/G)
VIKING GLOBAL INVESTORS LP Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Celldex Therapeutics, Inc.Sold outFebruary 14, 202300.0%
Coupa Software IncSold outFebruary 14, 202300.0%
FIGS, Inc.Sold outFebruary 14, 202300.0%
Guardant Health, Inc.February 14, 20234,107,6444.0%
Orion Acquisition Corp.Sold outFebruary 14, 202300.0%
PROCEPT BioRobotics CorpSold outFebruary 14, 202300.0%
Frazier Lifesciences Acquisition CorpSold outNovember 25, 202200.0%
Cazoo Group LtdNovember 10, 202260,000,0007.3%
AbCellera Biologics Inc.Sold outFebruary 14, 202200.0%
Athira Pharma, Inc.Sold outFebruary 14, 202200.0%

View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.

Latest filings
TypeFiled
42024-06-18
42024-06-18
SC 13G/A2024-06-18
32024-06-07
SC 13G2024-06-07
42024-06-03
SC 13G/A2024-06-03
13F-HR2024-05-15
32024-03-20
SC 13G/A2024-03-20

View VIKING GLOBAL INVESTORS LP's complete filings history.

Compare quarters

Export VIKING GLOBAL INVESTORS LP's holdings